VTC Ventures Research
Investment Thesis
VTC Ventures invests in early-stage healthcare and high-growth technology companies. It is not a generalist fund. Its focus follows the expertise of its strategic limited partners, Carilion Clinic, one of Virginia's major healthcare systems, and Virginia Tech, a leading research university. The fund invests where those partners can add real insight, access and validation, and it uses them to source, diligence and support companies from the earliest stages.
Focus Areas
The fund splits its capital roughly 60% healthcare and 40% technology, with food and agriculture as a third area informed by Virginia Tech's agricultural science.
- Healthcare: therapeutic development (as early as lead candidate finalization), medical devices and diagnostics (minimally invasive techniques, monitoring), and health tech that improves patient care and operational efficiency.
- Deep tech and technology: robotics, autonomous systems and sensors, AI applications for business and defense decision support, and cybersecurity, with an emphasis on dual-use defense and AI.
- Food and agriculture: specialty ingredients, food-as-medicine, consumer brands, robotics for farming and food manufacturing, digitization, and supply chain optimization.
Stage Focus and Check Size
VTC Ventures writes initial checks of $200K to $1M at the seed and early venture stage, and typically reserves one to three times the initial check for follow-on investment. It accepts instruments from SAFEs to preferred equity.
Lead Tendency
The fund will lead rounds but is equally willing to follow. It describes a collaborative mindset with other funds and says it will help companies raise the rest of a round even when it is not leading.
Geographic Focus
The fund has no geographic restriction. It prioritizes companies with ties to the Virginia Tech Carilion ecosystem, including homegrown ventures from Virginia Tech, Carilion Clinic or Southwest Virginia, and companies willing to build relationships there after investment, for example by running clinical or animal studies with partner institutions, co-developing with university research teams, working with the Fralin Biomedical Research Institute, or building remote technical teams in the Roanoke-Blacksburg corridor. A pre-existing connection is not required.
What Portfolio Companies Get
- Clinical validation: access to hospital systems, patient populations and clinical trial infrastructure.
- Research excellence: university laboratories, engineering talent and intellectual property resources.
- Operational insight: guidance from healthcare operators and deep tech leaders on workflows and scaling.
Portfolio Highlights
The fund lists portfolio companies across healthcare, technology and agtech, plus a group of Southwest Virginia companies. Named companies include Klarivis, The Tiny Cargo Company, Veracity, Card Isle, Modify Health, Earth Optics, Growers Exit, Atalan, Sedaro, Swarm Engineering and Brainbox Solutions. The fund does not publish the stage or date of its investments.
Team
- James Ramey, General Partner: joined Middleland Capital in 2016 to launch the VTC Innovation Fund. Nearly ten years in venture capital and private equity. Holds board or observer seats at companies including Farmer Focus, Earth Optics, CytoRecovery, PlanetIQ, MetiStream and BRAINBox. JD from the University of Nebraska.
- Brian Mixer, General Partner: joined Middleland Capital in 2009 and has invested in food and agtech for 15 years. Board or observer seats include Aerofarms, Arable Labs, Agrivida, Aquaspy, BIOHM Health, Groundwork Bio Ag, Sentera and Soli Organic. BA from Bucknell and MBA from Wharton.
- Greg Fisher, Senior Analyst: joined Middleland Capital in 2023. BBA and BA from Roanoke College.
Decision Process
The fund is managed by Middleland Capital, a thematic venture firm focused on food and agtech, with the general partners making investment decisions. The most effective route in is a warm introduction from the network, but the team says it examines all inbound opportunities regardless of origin.
Founder Preferences
The fund favors founders whose work overlaps with its partners' expertise: clinical problems Carilion sees, or research strengths at Virginia Tech in AI, advanced materials, national security, robotics, agriculture and food technology. It says it takes all deal flow seriously and only makes introductions into its LP network when they help both the company and the investors.
Recent Activity
The fund traces to the VTC Innovation Fund, formed in 2018 by the Virginia Tech Foundation and Carilion Clinic, which invested in PlanetIQ alongside New Science Ventures and AV8 Ventures. It also runs a smaller VTC Seed Fund for earlier, smaller checks. The firm does not publish recent deal dates or fund size.